StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Armata Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Armata Pharmaceuticals's market cap was $144.50M on Nov 11, 2026, against $268.61M a year earlier. Over the last 5 years it ranged from $41.20M to $392.00M, with a median of $108.38M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$144.50M-37.2%
2025Dec 31, 2025$230.13M+243.8%
2024Dec 31, 2024$66.94M-42.8%
2023Dec 29, 2023$117.04M+161.1%
2022Dec 30, 2022$44.82M-67.2%
2021Dec 31, 2021$136.81M+145.5%
2020Dec 31, 2020$55.72M+72.6%
2019Dec 31, 2019$32.29M+375.2%
2018Dec 31, 2018$6.79M-63.9%
2017Dec 29, 2017$18.84M+92.5%
2016Dec 30, 2016$9.79M-79.1%
2015Dec 31, 2015$46.83M-40.4%
2014Dec 31, 2014$78.61M–

More Armata Pharmaceuticals figures

See a number that looks wrong?